Pharmaceutical Supply of Methocarbamol Tablets

This contract involves the manufacture or sourcing of Methocarbamol Tablets, USP, ensuring compliance with FDA regulations, United States Pharmacopeia standards, and current Good Manufacturing Practices (cGMP). The scope includes comprehensive stability testing and detailed documentation to maintain quality and regulatory adherence throughout the production process. The contract is categorized under the NAICS code 325412, which relates to pharmaceutical manufacturing. Issued by the Defense Logistics Agency under the Department of Defense, this subcontract opportunity was posted on May 28, 2026, with a response deadline of June 3, 2026. Although specific details on the location of performance and point of contact are not provided, potential suppliers must be capable of meeting the stringent regulatory requirements and delivering high-quality Methocarbamol Tablets as specified by the government. The contract’s purpose aligns with supporting pharmaceutical supply needs within the Department of Defense.